INCY
Incyte Corp
$114.26
0.51 (0.45%) Today
— up— down
Market Cap
$22.73B+67.3%
Revenue (TTM)
$5.18B+21.5%
Net Income (TTM)
$1.41B+2455.3%
EPS (TTM)
7.07+2455.3%
Shares Out
199.78M
199.78MP/E Ratio
15.87
15.87Forward P/E
12.58
12.58Open
$115.48
$115.48Previous Close
$113.75
$113.75Day Range
$112.89 – $115.48
$112.89 – $115.4852-Week Range
$66.83 – $115.56
$66.83 – $115.56Beta
0.73
0.73Volume
753.56K
753.56KAvg Volume
1.67M
1.67MAnalyst Rating
Buy
BuyExchange
NASDAQ NMS - GLOBAL MARKET
NASDAQ NMS - GLOBAL MARKETAbout INCY
Incyte Corporation is an American multinational pharmaceutical company with headquarters in Wilmington, Delaware. The company currently operates manufacturing and R&D locations in North America, Europe, and Asia.
Related
News
N/A
N/AN/AN/A
Incyte (INCY) Surges 5.8%: Is This an Indication of Further Gains?
Yahoo · 5h ago
Incyte: New Catalysts Support Another Leg Higher
SeekingAlpha · 10h ago
Incyte (INCY) Stock After 66% One-Year Rally Is The Market Too Optimistic Now
Yahoo · 2d ago
Incyte (INCY) Wins EU Backing For Opzelura As Pipeline Data Builds Across Four Drugs
Yahoo · 2d ago
UBS Maintains Neutral on Incyte, Raises Price Target to $113
Benzinga · 3d ago